WuXi Biologics Launches Next-Generation Platform WuXiHigh™2.0 for High-Concentration Biologics with Protein Concentration Reaching 230 mg/mL
NLS Pharmaceutics and Kadimastem Announce Pricing and Closing of $1 Million Equity Financing
Oncolytics Biotech® Appoints Former Ambrx Executive as Chief Business Officer to Drive Business Development Strategy
CarobWay Launches Food-Forward Prebiotic Fiber Innovation at IFT